.png){kind=logo}
GC Asia
Cerba Lab raises €80m for acquisition of JS Bio
Cerba European Lab, the French clinical pathology testing business, issued an €80m high yield bond tap on Thursday to finance its acquisition of JS Bio.
Goldman Sachs was the only bookrunner on the 5.7 year (February 2020) deal, which was announced as a drive-by on Thursday morning.
The deal is a tap of a €365m issue that Cerba sold in January 2013. The senior secured bonds are rated B2/B+/BB-.
At around midday London time, Goldman ...Already a subscriber? Login
-
Latest news from Corporate Bonds
-
Second AGM motion jabs Barclays on fossil fuel support
26 Feb 2021 -
HIG Capital hires another MD for European direct lending biz
26 Feb 2021 -
Vedanta builds war chest for corporate revamp
26 Feb 2021 -
Fantasia, Sunac find demand for new bonds
26 Feb 2021 -
GlobalCapital Syndicated Loan, Leveraged Finance and Private Debt Awards 2020: the full results
26 Feb 2021
-
-
Latest news from Corporate Bonds
-
Second AGM motion jabs Barclays on fossil fuel support
26 Feb 2021 -
HIG Capital hires another MD for European direct lending biz
26 Feb 2021 -
Vedanta builds war chest for corporate revamp
26 Feb 2021 -
Fantasia, Sunac find demand for new bonds
26 Feb 2021 -
GlobalCapital Syndicated Loan, Leveraged Finance and Private Debt Awards 2020: the full results
26 Feb 2021
-
